The Indian pharmaceutical industry is highly fragmented with about 10,000 manufacturing units (300 in the organized sector). The top ten companies make up for
more than third of the market. India accounts for about 8% of the world's pharma pie in volume terms, but only 1% in value terms.
Will the recently introduced Patent Regime change all that?